Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0079731 (
B-cell lymphoma
)
16,671
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Kostmann
syndrome, or
severe congenital neutropenia
(
SCN
), is an autosomal recessive disorder of neutrophil production. To investigate the potential role of apoptosis in
SCN
, bone marrow aspirates and biopsies were obtained from 4 patients belonging to the kindred originally described by
Kostmann
and 1 patient with
SCN
of unknown inheritance. An elevated degree of apoptosis was observed in the bone marrow of these patients, and a selective decrease in
B-cell lymphoma
-2 (Bcl-2) expression was seen in myeloid progenitor cells. Furthermore, in vitro apoptosis of bone marrow-derived
Kostmann
progenitor cells was increased, and mitochondrial release of cytochrome c was detected in CD34(+) and CD33(+) progenitors from patients, but not in controls. Administration of granulocyte colony-stimulating factor (G-CSF) restored Bcl-2 expression and improved survival of myeloid progenitor cells. In addition, cytochrome c release was partially reversed upon incubation of progenitor cells with G-CSF. In sum, these studies establish a role for mitochondria-dependent apoptosis in the pathogenesis of
Kostmann
syndrome and yield a tentative explanation for the beneficial effect of growth factor administration in these patients.
...
PMID:Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. 1476 41